Pro-opiomelanocortin gene delivery suppresses the growth of established Lewis lung carcinoma through a melanocortin-1 receptor-independent pathway

Journal of Gene Medicine

Volumn 14, Issue 1, 2012, Pages 44-53

  Tsai, Han En ^a   Liu, Li Feng ^b   Dusting, Gregory J ^c   Weng, Wen Tsan ^d   Chen, San Cher ^e   Kung, Mei Lan ^a   Tee, Richard ^a   Liu, Guei Sheung ^c   Tai, Ming Hong ^c  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c O'Brien Institute   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

catenin; Gene therapy; Lung cancer; MC1R; POMC

Indexed keywords

BETA CATENIN; CYCLIN D1; MELANOCORTIN 1 RECEPTOR; MYC PROTEIN; PROOPIOMELANOCORTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CELL STRUCTURE; COLONY FORMATION; CONTROLLED STUDY; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

ANIMALS; APOPTOSIS; BETA CATENIN; CARCINOMA, LEWIS LUNG; CELL PROLIFERATION; DISEASE PROGRESSION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC THERAPY; HUMANS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; PRO-OPIOMELANOCORTIN; RECEPTOR, MELANOCORTIN, TYPE 1; SIGNAL TRANSDUCTION;

MUS;

EID: 84862908186     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1625     Document Type: Article

References (26)

1. Nakanishi S. Regulatory mechanisms for the synthesis of liver acetyl-CoA carboxylase and pituitary corticotropin-beta-lipotropin precursor (author's translation). Seikagaku 1979; 51: 1108-1126.
2. Solomon S. POMC-derived peptides and their biological action. Ann NY Acad Sci 1999; 885: 22-40.
3. Raffin-Sanson ML, de Keyzer Y, Bertagna X. Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol 2003; 149: 79-90.
4. Todorovic A, Haskell-Luevano C. A review of melanocortin receptor small molecule ligands. Peptides 2005; 26: 2026-2036.
5. Catania A, Gatti S, Colombo G, et al. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 2004; 56: 1-29.
6. Rana BK. New insights into G-protein-coupled receptor signaling from the melanocortin receptor system. Mol Pharmacol 2003; 64: 1-4.
7. Taherzadeh S, Sharma S, Chhajlani V, et al. alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte/macrophages. Am J Physiol 1999; 276: R1289-R1294.
8. Rouzaud F, Kadekaro AL, Abdel-Malek ZA, et al. MC1R and the response of melanocytes to ultraviolet radiation. Mutat Res 2005; 571: 133-152.
9. Gerstenblith MR, Goldstein AM, Fargnoli MC, et al. Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat 2007; 28: 495-505.
10. Liu GS, Liu LF, Lin CJ, et al. Gene transfer of pro-opiomelanocortin prohormone suppressed the growth and metastasis of melanoma: involvement of alpha-melanocyte-stimulating hormone-mediated inhibition of the nuclear factor kappaB/cyclooxygenase-2 pathway. Mol Pharmacol 2006; 69: 440-451.
11. Liu GS, Tsai HE, Weng WT, et al. Systemic pro-opiomelanocortin expression induces melanogenic differentiation and inhibits tumor angiogenesis in established mouse melanoma. Hum Gene Ther 2011; 22: 325-335.
12. Tai MH, Cheng H, Wu JP, et al. Gene transfer of glial cell line-derived neurotrophic factor promotes functional recovery following spinal cord contusion. Exp Neurol 2003; 183: 508-515.
13. Tai MH, Wang LL, Wu KL, et al. Increased superoxide anion in rostral ventrolateral medulla contributes to hypertension in spontaneously hypertensive rats via interactions with nitric oxide. Free Radic Biol Med 2005; 38: 450-462.
14. Jiang F, Zhang G, Hashimoto I, et al. Neovascularization in an arterio-venous loop-containing tissue engineering chamber: role of NADPH oxidase. J Cell Mol Med 2008; 12: 2062-2072.
15. Uematsu K, He B, You L, et al. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 2003; 22: 7218-7221.
16. Huang CL, Liu D, Ishikawa S, et al. Wnt1 overexpression promotes tumour progression in non-small cell lung cancer. Eur J Cancer 2008; 44: 2680-2688.
17. Lam HC, Kuo SM, Chuang MJ, et al. Blockade of endothelin-1 release contributes to the anti-angiogenic effect by pro-opiomelanocortin overexpression in endothelial cells. Exp Biol Med (Maywood) 2006; 231: 782-788.
18. Matichard E, Verpillat P, Meziani R, et al. Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 2004; 41: E13.
19. Peris K, Fargnoli MC, Pacifico A, et al. CDKN2A and MC1R mutations in patients with sporadic multiple primary melanoma. J Invest Dermatol 2004; 122: 1327-1330.
20. Stratigos AJ, Dimisianos G, Nikolaou V, et al. Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. J Invest Dermatol 2006; 126: 1842-1849.
21. Abdel-Malek ZA. Development of alpha-melanocortin analogs for melanoma prevention and targeting. Adv Exp Med Biol 2010; 681: 126-132.
22. Paul S, Dey A. Wnt signaling and cancer development: therapeutic implication. Neoplasma 2008; 55: 165-176.
23. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-1512.
24. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-426.
25. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002; 29: 15-18.
26. Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002; 2: 727-739.